Research


June 28, 2022

NIH Funds UAMS Study Testing Rapid Genomic Surveillance for Antibiotic Resistant Infections

David Robinson

Se-Ran Jun, Ph.D., discusses her TRI pilot award-supported findings with Fred Prior, Ph.D., distinguished professor and chair of the Department of Biomedical Informatics, at TRI Research Day in April.

A University of Arkansas for Medical Sciences (UAMS) study is developing real-time and accurate genomic methods that can be used routinely to deliver life-saving information to doctors treating antibiotic-resistant infections. Backed by a two-year, $418,000 National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant, UAMS’ Se-Ran Jun, Ph.D., says the…


June 27, 2022

UAMS’ Eric Peterson, Ph.D., Named Executive Vice President of BioVentures LLC

David Robinson

Eric Peterson, Ph.D.

LITTLE ROCK — Eric Peterson, Ph.D., has been named executive vice president of BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS). Peterson is chair of the UAMS Patent and Copyright Committee and is an associate professor in the College of Medicine Department of Pharmacology and Toxicology. As executive vice president, he will…


June 22, 2022

NCI Funds UAMS Study of Possible Links between Gammaherpesvirus Infections and Lymphomas

Seth Hooker

Craig Forrest, Ph.D.

LITTLE ROCK — A possible link between gammaherpesviruses and lymphomas will receive further study at the University of Arkansas for Medical Sciences (UAMS) with a National Cancer Institute (NCI) grant. The five-year, $1.25 million grant renewal will mostly support ongoing work to better understand how gammaherpesvirus promotes mutations (chromosomal translocations) that lead to lymphomas. In…


June 10, 2022

Cancer Institute Retreat Highlights Novel Therapeutic Targets and Agents

Marty Trieschmann

Jungang Chen, a postdoctoral fellow in the UAMS Department of Pathology, discusses his research on pathogenesis and tumorgenesis in Covid-19 patients infected with Herpes

The Winthrop P. Rockefeller Cancer Institute held its second annual scientific research retreat May 26 at the Marriott Hotel in Little Rock. More than 140 scientists gathered in person for the first time in two years. The retreat theme, “Molecular Targets and Cancer Therapeutics,” reflects the growth in the identification of new and novel molecular…


June 9, 2022

Arkansas Undergraduates ‘Speed Date’ with Research at UAMS Obesity and Diabetes Workshop

Seth Hooker

UAMS’ Emir Tas, M.D., (left) leads a table discussion about fatty liver disease and the benefits of high-intensity interval training.

The University of Arkansas for Medical Sciences (UAMS) presented undergraduate students with an opportunity to learn more about obesity and diabetes at a uniquely structured workshop May 25. The workshop, hosted by Arkansas INBRE (IDeA Network of Biomedical Research Excellence), was attended by 15 students from around the state. There were presentations from seven UAMS…


June 7, 2022

UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East

David Robinson

U.S. Marines with 1st Marine Logistics Group view burn pit at Al Taqaddum Air Base, Iraq, Sept. 22, 2008.

LITTLE ROCK — More than 300 Arkansas veterans will become part of a new study conducted by the University of Arkansas for Medical Sciences (UAMS) and the Central Arkansas Veterans Healthcare System (CAVHS) to determine if exposure to open pit burning and molecular-level changes are associated with chronic health conditions. The Department of Veterans Affairs…


June 2, 2022

UAMS Study First to Test When Common Arsenic Exposures Are Most Likely to Cause Male Infertility in Offspring

David Robinson

Shuk-Mei Ho, Ph.D., and Yuet-Kin "Ricky" Leung, Ph.D., are leading the five-year, $2.54 million arsenic study.

LITTLE ROCK — In the first study of its kind, researchers at the University of Arkansas for Medical Sciences (UAMS) will test when exposure to inorganic arsenic —  a common, harmful environmental toxin — is most likely to lead to infertility traits that may last for generations. The study, supported by a five-year, $2.54 million…


June 1, 2022

Study Shows That Arkansas Minorities Experienced Abnormally High Rates of COVID-19 Infection

Kev' Moye

COVID-19 Vaccination

LITTLE ROCK — Researchers from multiple Arkansas agencies conducted an eight-month study which revealed that the state’s Hispanic and Black populations had higher COVID-19 infection rates than whites. This project, which Open Forum Infectious Disease published, used seroprevalence of antibodies to COVID-19 as an indicator. Antibodies are created by a person’s immune system once they…


May 26, 2022

Four UAMS Faculty Receive 2022 Provost’s Innovator Awards

David Robinson

The awardees are Lisa Brents, Ph.D., Lyle Burdine, M.D., Ph.D., Craig Forrest, Ph.D., and Gresham Richter, M.D.

The University of Arkansas for Medical Sciences (UAMS) announced four UAMS faculty as recipients of the Provost’s Innovator Awards. The awards were established by Stephanie Gardner, Pharm.D., Ed.D., UAMS provost and chief strategy officer, and Shuk-Mei Ho, Ph.D., vice chancellor for Research and Innovation. The grants of $25,000 each support groundbreaking, innovative, high-impact projects that…


May 23, 2022

UAMS Begins Final Study of First Rapid Test for Acetaminophen Toxicity with $3.2 Million Grant

David Robinson

Laura James, M.D., hopes the final phase of research will lead to FDA approval of the rapid test for acetaminophen toxicity.

The first rapid diagnostic test for acetaminophen toxicity has cleared a major hurdle on its long road to the marketplace from UAMS.



Next page